title: Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole.
authors.affiliation: Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Calcagno
authors.forename: Alice
authors.initials: A
authors.lastname: Trentalange
authors.forename: Marco
authors.initials: M
authors.lastname: Simiele
authors.forename: Letizia
authors.initials: L
authors.lastname: Marinaro
authors.forename: Francesca
authors.initials: F
authors.lastname: Patti
authors.forename: Maria C
authors.initials: MC
authors.lastname: Tettoni
authors.forename: Laura
authors.initials: L
authors.lastname: Trentini
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Perri
authors.forename: Antonio
authors.initials: A
authors.lastname: DʼAvolio
authors.forename: Stefano
authors.initials: S
authors.lastname: Bonora
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000493:pharmacokinetics*; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D000077402:Pantoprazole; D000068696:Rilpivirine / Q000493:pharmacokinetics*
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D019380:Anti-HIV Agents; D000077402:Pantoprazole; D000068696:Rilpivirine